Listed

PharmaCyte Biotech, Inc.

PMCBNasdaqCIK 1157075HealthcareFiscal year ends Apr 30

Reports and events: 211 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

PharmaCyte Biotech, Inc., Reports and events
FiledFormWhat it isAccession number
2022-11-0717:00 ET8-K5.02 Departure or appointment of officers or directors0001683168-22-007359
2022-10-1416:12 ET8-K5.02 Departure or appointment of officers or directors; 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-006911
2022-10-0716:53 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-22-006803
2022-09-1416:29 ET10-QQuarterly reportPeriod 2022-07-310001683168-22-006394
2022-08-1618:55 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-22-005782
2022-08-1517:38 ETSC 13D/AOwnership report, active investor, amended0000921895-22-002477
2022-07-2817:29 ET10-KAnnual reportPeriod 2022-04-300001683168-22-005189
2022-07-2817:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-005186
2022-07-2114:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-005063
2022-07-1917:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-005036
2022-07-1117:11 ETSC 13D/AOwnership report, active investor, amended0000921895-22-002213
2022-07-1116:21 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-004874
2022-06-2315:40 ETSC 13D/AOwnership report, active investor, amended0000921895-22-002076
2022-06-1508:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-22-004361
2022-06-0721:50 ET8-K5.08 Item not in the standard list; 8.01 Other events0001683168-22-004190
2022-04-1307:39 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events0001683168-22-002580
2022-04-0506:01 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-22-002335
2022-03-1517:16 ET10-QQuarterly reportPeriod 2022-01-310001683168-22-001694
2022-03-0917:24 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-22-001550
2022-03-0120:50 ET8-K3.01 Delisting notice0001683168-22-001345
2022-02-1717:14 ET8-K3.01 Delisting notice0001683168-22-001119
2021-12-1417:16 ET10-QQuarterly reportPeriod 2021-10-310001683168-21-006337
2021-11-0407:38 ETSC 13DOwnership report, active investor0000930413-21-001835
2021-09-1408:01 ET10-QQuarterly reportPeriod 2021-07-310001683168-21-004264
2021-09-1018:44 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-21-004199
2021-08-2306:01 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-21-003829
2021-08-1221:58 ET8-K1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001683168-21-003431
2021-08-1006:03 ET10-KAnnual reportPeriod 2021-04-300001683168-21-003377
2021-08-0217:12 ET8-K8.01 Other events0001683168-21-003222
2021-07-1319:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-002921
2021-07-0620:23 ET8-K5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-002825
2021-06-2220:51 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-002661
2021-06-1521:14 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-002553
2021-06-0421:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-002359
2021-05-0621:36 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-21-001793
2021-03-1217:11 ET10-QQuarterly reportPeriod 2021-01-310001683168-21-000925
2020-12-1116:47 ET10-QQuarterly reportPeriod 2020-10-310001683168-20-004267
2020-10-1616:57 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001683168-20-003473
2020-09-1116:27 ET10-QQuarterly reportPeriod 2020-07-310001683168-20-003111
2020-08-1317:05 ET10-KAnnual reportPeriod 2020-04-300001683168-20-002680
2020-07-2916:34 ETSC 13D/AOwnership report, active investor, amended0001753926-20-000215
2020-05-0614:19 ETSC 13DOwnership report, active investor0001753926-20-000100
2020-04-0808:00 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001683168-20-001127
2020-03-1316:47 ET10-QQuarterly reportPeriod 2020-01-310001683168-20-000802
2020-01-2117:15 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001683168-20-000204
2019-12-2316:37 ET10-QQuarterly reportPeriod 2019-10-310001683168-19-004051
2019-11-0817:27 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001683168-19-003515
2019-10-0316:01 ET8-K5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001683168-19-003157
2019-09-1317:16 ET10-QQuarterly reportPeriod 2019-07-310001683168-19-002926
2019-08-2608:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001683168-19-002754

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 14, 2026, 20:52 ET. Listed shows no prices and gives no investment advice.